 |
Keyword Search |
 |
|
|
| |
|
|
|
Return to Digital Conference Providers Inc. Events Library Menu
 |
Steve Stanko
Biography
Steve Stanko has worked with Mended Hearts for 21 years and currently
serves as the Chapter President of the Southern Nevada region. In 2008, Steve
was selected as the Advocate of the Year by the Southern Nevada Chapter
of the AHA. He was recently appointed as a member of the State of Nevada
Advisory Committee for the Prevention and Treatment of Stroke and Heart
Disease, and he continues to serve Mended Hearts as Chair of the Cath Patient
Outreach Program a joint effort by Mended Hearts and SCAI to offer
support and information to patients undergoing catheter-based procedures.
Affiliation
Website
|
|
Steve Stanko Steve Stanko has worked with Mended Hearts for 21 years and currently
serves as the Chapter President of the Southern Nevada region. In 2008, Ste (more ...) |
|
David Annis
Biography
President, NACUFS
Affiliation
NACUFS
Website
|
|
Peggy B. Bourgeois, APRN, MN, CNS, CDE, CEC
Biography
Affiliation
Website
|
|
Peggy B. Bourgeois, APRN, MN, CNS, CDE, CEC (more ...) |
 |
Lee Ann Brady
Biography
Scottsdale, Executive Vice President for Clinical
Education, The Spear Institute
Affiliation
Website
|
|
Lee Ann BradyScottsdale, Executive Vice President for Clinical
Education, The Spear Institu (more ...) |
|
Howard Fillit MD
Biography
Howard Fillit, MD, a geriatrician and neuroscientist, is the founding Executive Director of the Institute for the Study of Aging, Inc. as well as its affiliated public charity the Alzheimers Drug Discovery Foundation, both of which are dedicated to funding drug discovery for Alzheimer's disease. Dr. Fillit was formally the Corporate Medical Director for Medicare at NYLCare Health Plans (now a division of Aetna, Inc.), where he was responsible for over 125,000 Medicare members in 8 regional markets. He has also had a distinguished academic career at The Rockefeller University and The Mount Sinai Medical Center (NY), where he is currently a clinical professor of geriatrics and medicine and a professor of neurobiology. Dr. Fillit has received many awards and honors, including the Rita Hayworth Award for Lifetime Achievement from the Alzheimer's Association. He is a fellow of the American Geriatrics Society, the American College of Physicians, the Gerontological Society of America, and the New York Academy of Medicine. Dr. Fillit is the author or co-author of more than 250 publications, including the leading international Textbook of Geriatric Medicine and Gerontology. He served as a consultant to a variety of individuals, managed care organizations, health care systems, and pharmaceutical and biotechnology companies.
Affiliation
Website
|
|
Howard Fillit MDHoward Fillit, MD, a geriatrician and neuroscientist, is the founding Executive Director of the Institute for the Study of Aging, Inc. as well as (more ...) |
|
James Inglese, PhD
Biography
Dr. Inglese is currently establishing the Laboratory of Assay and Screening Technology Development focused on rare and neglected diseases in the newly formed NIH Center for Translational Therapeutics (NCTT). He is also co-founder of the NIH Chemical Genomics Center (NCGC) and Associate Investigator of the National Human Genome Research Institute (NHGRI). Dr. Inglese received his Ph.D. in Organic Chemistry from the Pennsylvania State University and completed post-doctoral training in the laboratory of Prof. Robert J. Lefkowitz at Duke University Medical Center. Dr. Inglese has led research teams at the Princeton-based biotech Pharmacopeia and Merck Research Laboratories before coming to the NIH. Over the past two decades Dr. Inglese has contributed to over 150 publications and patents and has made major contributions to the early drug discovery process through the development of novel assay formats and high throughput screening paradigms. Dr. Inglese is the Founding Editor (2002) and Editor-in-Chief of the journal, ASSAY and Drug Development Technologies.
Affiliation
Website
|
|
James Inglese, PhDDr. Inglese is currently establishing the Laboratory of Assay and Screening Technology Development focused on rare and neglected diseases in the n (more ...) |
 |
Kathleen Kennedy Townsend
Biography
Kathleen Kennedy Townsend, eldest child of Robert and Ethel Kennedy, two-time lieutenant governor and now a superdelegate from Maryland, opens our conference three days after the national election. Her message shares the title of her 2007 book. There is an appropriate role for religion in politics, she writes, one that reconciles the liberating vision of the Founding Fathers with values born of faith, such as those contained in Leo XIIIs Rerum Novarum. In this election, she thinks America may be ready. Is she right? Kennedy Townsend is also passionate about reforming the churches, especially her own Catholic Church. She is inspired by Charlie Curran and Theresa Kane, her fellow board members at the National Catholic Reporter. After Vatican II the Church she loves lost its way, chiefly on questions of women and sex. But her book credits Dan and Sheila Daley for founding the independent CTA movement to reform the Church from below. And like CTA, she labors to change the Church so that the Church can serve the common good, especially those in poverty.
Affiliation
Website
|
|
Kathleen Kennedy TownsendKathleen Kennedy Townsend, eldest child of Robert and Ethel Kennedy, two-time lieutenant governor and now a superdelegate from Maryland, opens our (more ...) |
|
Lisa Kivirist
Biography
Operator of self-sustaining Inn Serendipity
Affiliation
Serendipity
Website
|
|
Lisa KiviristOperator of self-sustaining Inn Serendi (more ...) |
|
Cynthia Robbins Shah-Khan
Biography
Affiliation
Website
|
|
Alan Snow, PhD
Biography
Dr. Alan Snow is Chairman, President and Chief Scientific Officer of ProteoTech Inc., a private Company that is developing a pipeline of drugs targeting amyloid diseases including Alzheimer's, Parkinson's, systemic amyloidosis and type 2 diabetes. He previously served as a Research Associate Professor of Pathology at University of Washington (Seattle, WA) and is a world-recognized authority on amyloid diseases. He holds a B.S. degree in Biology/Chemistry from Bowling Green State University in Ohio, a M.S. degree in Anatomy from University of Western Ontario (Canada), and a Ph.D. in Pathology from Queen's University (Canada). His Ph.D. research led to new discoveries pertaining to the pathogenic role that proteoglycans play in amyloid diseases. Dr. Snow founded ProteoTech and left the University of Washington in 1999 to serve as the Company's first CEO. Currently, two small molecule drugs are in human clinical trials that were developed at ProteoTech:
1) Exebryl-1 targeting both beta-amyloid protein and tau protein for Alzheimer's disease and
2) SystebrylTM targeting AA amyloid for systemic AA amyloidosis. Other drugs in ProteoTech's pipeline in late pre-clinical development include the small molecule SynuclereTM targeting alpha-synuclein aggregates in Parkinson's disease, and the small D-amino acid peptide, PepticlereTM targeting beta-amyloid protein for Alzheimer's disease.
Since being at ProteoTech Dr. Snow has acquired over $15 million in grant funding, and is an inventor on over 100 issued patents pertaining to the development of new drugs for different amyloid diseases.
Affiliation
Website
|
|
Alan Snow, PhDDr. Alan Snow is Chairman, President and Chief Scientific Officer of ProteoTech Inc., a private Company that is developing a pipeline of drugs tar (more ...) |
PREV10 - 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 - NEXT10
|
All Libraries
|
